THE ASSOCIATION BETWEEN SERUM VALUES OF OSTEOCALCIN AND THE PARAMETERS OF METABOLIC SYNDROME.
- Conditions
- Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases
- Registration Number
- CTRI/2019/02/017395
- Lead Sponsor
- Kasturba hospital manipal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Individuals above the age of 18.
According to the NCEP-ATP III guidelines using Asian adaptation the inclusion criteria were defined as meeting three or more of the following five factors.
1. Central obesity- waist circumference > 90cm in males, >80cm in females.
2. Low HDL cholesterol- < 40mg/dl or under treatment.
3. High serum triglycerides- >150mg/dl or under treatment.
4. Increased blood pressure- >135/80 or under treatment.
5. Fasting plasma glucose >100mg/dl or under treatment.
Patients who are unwilling to participate
Hyperparathyroidism, hypoparathyroidism, thyroid disorders, osteoporosis, rheumatoid arthritis, Cushing disease. Bone related malignancies, liver diseases, renal failure, pancrea!c gland dysfunction.
Use of oral contraceptives, hormone replacement therapy, steroid therapy, vitamin k., vitamin D, calcium, anti epileptic drugs, calcitonin, bisphosphonates, patients on insulin therapy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To establish an inverse relationship between serum osteocalcin and occurrence of metabolic syndromeTimepoint: 2 years
- Secondary Outcome Measures
Name Time Method To establish a relationship between serum osteocalcin and various other parameters of metabolic syndromeTimepoint: 2 years